CMS Reveals Limited Digital Health Policies in Final Medicare Rule


In a move that has drawn considerable attention just days before the 2024 presidential election, the Centers for Medicare & Medicaid Services (CMS) has released the final calendar year 2025 physician fee schedule (PFS) rule. This rule, which impacts digital therapeutics, telehealth, rural health clinics, and opioid treatment programs, underscores CMS’s limited authority in shaping digital health payment policies.
Digital Health Policies
CMS has finalized several digital health policies, as initially proposed in July’s draft rule. However, the offerings remain modest. New codes have been introduced for digital therapeutics, particularly aimed at mental healthcare. These changes mainly involve redefining existing codes to distinguish them from remote therapeutic monitoring codes. CMS’s authority in this area is limited, prompting a call for congressional action to create a new benefit category for digital therapeutics.
Telehealth Policies
With the expiration of Medicare telehealth flexibilities looming at the end of 2024, CMS has highlighted the necessity for Congress to extend key telehealth waivers. These waivers have significantly expanded telehealth services since 2020. Permanent coverage for audio-only visits and direct supervision via telehealth has been confirmed, yet geographical and origin site restrictions continue to pose challenges. For further details, you can refer to the original article.
Rural Health Clinics and Federally Qualified Health Centers
CMS has been striving to achieve payment parity for telehealth services compared to in-person services in rural health clinics and federally qualified health centers. While a special payment rate is applied for telehealth, CMS has opted to retain its current payment methodology for now, though reforms may be considered in the future.
Opioid Treatment Programs
The rule acknowledges the importance of telehealth in opioid treatment programs, especially for older Medicare beneficiaries who rely heavily on audio-only services. CMS will allow telehealth usage for periodic assessments, marking a step forward in addressing opioid use disorder through digital means.
For a comprehensive understanding of the finalized rule and its implications, visit the CMS Federal Register.

Conclusion


While CMS has made some progress, the agency emphasizes the need for congressional action to broaden and secure these developments. The future of digital health policies remains uncertain, with much depending on legislative support.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Artificial Intelligence in Diagnostics: A Revolution in Healthcare

The global market for artificial intelligence in diagnostics is poised for remarkable growth, with projections estimating it to reach USD 7.3 billion by 2032.

By |December 10, 2024|Categories: Article, Artificial Intelligence, Healthcare|Tags: , |0 Comments

Revolutionizing Medical Education with Extended Reality

In the ever-evolving landscape of medical education, a new player has emerged, promising to revolutionize the way future doctors are trained. The integration of eXtended Reality (XR) technologies is reshaping the educational landscape by addressing the limitations of traditional methods.

Genetic Testing: A New Dawn in Healthcare

Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness.

Sustainable Architecture: Blending Innovation with Ecological Responsibility

The journey toward sustainable architecture is ongoing, with each project serving as a beacon of what's achievable when creativity meets ecological awareness.

By |December 9, 2024|Categories: Architecture, Article, Sustainability|Tags: |0 Comments

AI in Clinical and Molecular Diagnostics: A Market on the Rise

AI in Clinical and Molecular Diagnostics Market is set to experience remarkable growth, projected to surge from USD 2.6 billion in 2024 to USD 8.9 billion by 2029. This growth is driven by the integration of advanced AI technologies such as machine learning and deep learning into traditional diagnostic methodologies like imaging, genomics, and laboratory testing.

AI: A Revolution in Healthcare’s Future

AI is not a distant dream but a present reality, already integrated into everyday life through virtual assistants like Alexa and Siri. AI shows promise in enhancing medical accuracy, such as in predicting mesothelioma survival and improving colonoscopy accuracy, it is not intended to replace healthcare professionals.